MRKR MARKER THERAPEUTICS INC Other Situations 8-K Filing 2023 - Completion of Acquisition or Disposition of Assets Marker Therapeutics, Inc. completed the disposition of assets to Cell Ready for approximately $19.0 million, resulting in the company meeting the criteria for discontinued operations and providing unaudited pro forma financial statements.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC